A combination of factor Xa and phosphatidylcholine-phosphatidylserine vesicles bypasses factor VIII in vivo
Data up to Jan 2025
Total Citations Per Year
Abstract
References (25)
Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens
1957 • 3,280 citations
Molecular Weight Determination of Protein-Dodecyl Sulfate Complexes by Gel Electrophoresis in a Discontinuous Buffer System
1971 • 2,019 citations
The Journal of Laboratory and Clinical Medicine
2004 • 1,433 citations
Immunoblotting and dot immunobinding — Current status and outlook
1984 • 979 citations
The contribution of bovine Factor V and Factor Va to the activity of prothrombinase.
1979 • 592 citations
The inhibition of blood coagulation by activated protein C through the selective inactivation of activated factor V
1979 • 480 citations
Molecular mechanism of physiological fibrinolysis
1978 • 410 citations
The Effect of Activated Prothrombin-Complex Concentrate (FEIBA) on Joint and Muscle Bleeding in Patients with Hemophilia A and Antibodies to Factor VIII
1981 • 303 citations
Generation of fibrinolytic activity by infusion of activated protein C into dogs.
1981 • 303 citations
Efficacy of Prothrombin-Complex Concentrates in Hemophiliacs with Antibodies to Factor VIII
1980 • 257 citations
Use of human factor VIIa in the treatment of two hemophilia A patients with high-titer inhibitors.
1983 • 239 citations
Simultaneous Purification of Bovine Prothrombin and Factor X
1973 • 204 citations
Activated Prothrombin Concentrate for Patients with Factor VIII Inhibitors
1974 • 163 citations
Human prothrombin activation
1975 • 131 citations
A canine model of hemophilic (factor VIII:C deficiency) bleeding
1982 • 128 citations
Autoplex versus proplex: a controlled, double-blind study of effectiveness in acute hemarthroses in hemophiliacs with inhibitors to factor VIII
1983 • 125 citations
Factor VIII inhibitors
1985 • 109 citations
Intravascular Coagulation with Use of Human Prothrombin Complex Concentrates
1976 • 91 citations
The coagulant-active phospholipid content is a major determinant of in vivo thrombogenicity of prothrombin complex (Factor IX) concentrates in rabbits
1982 • 81 citations
Treatment of Anti-Factor VIII Antibodies
1977 • 80 citations
Evidence of normal functional levels of activated protein C inhibitor in combined Factor V/VIII deficiency disease.
1982 • 77 citations
[26] Protein C
1981 • 67 citations
Studies of Factors V and VIII:C in an animal model of disseminated intravascular coagulation.
1984 • 46 citations
FACTOR VIII INHIBITORS REVISITED
1981 • 35 citations
Isolation of human VAL354-plasminogen as an elastolytic fragment of human GLU1-plasminogen
1981 • 22 citations